Skip to content

13F-HR filed by Wildcat Capital Management, LLC

Wildcat Capital Management, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-15, with 16 holding rows worth $557,633,000.

Accession
0000903423-17-000679
Filed
2017-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 20 entries on the cover page, a total value of $557,633,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $557,633,000 with VALUE read as thousands by filing date, 13F file number 028-16579. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KITE PHARMA INC49803L109COM2,410,034$433,348,000thousands by filing date
COSTAR GROUP INC COM22160N109Stock176,827$47,434,000thousands by filing date
NANTKWEST INC63016Q102COM3,391,539$18,586,000thousands by filing date
LPL FINL HLDGS INC COM50212V100Stock208,401$10,693,000thousands by filing date
ISHARES TR464288281JPMORGAN USD EMG70,000$8,087,000thousands by filing date
SABINE RTY TR785688102UNIT BEN INT186,000$7,533,000thousands by filing date
COMMUNICATIONS SALES&LEAS IN20341J104COM410,700$6,021,000thousands by filing date
MIMEDX GROUP INC602496101COM500,000$5,940,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK2,799,790$4,760,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK135,000$4,255,000thousands by filing date
DAVE & BUSTERS ENTMT INC238337109COM60,000$3,149,000thousands by filing date
PLAYA HOTELS & RESORTS NVN70544106SHS300,000$3,129,000thousands by filing date
CURRENCYSHS JAPANESE YEN TR23130A102JAPANESE YEN31,245$2,667,000thousands by filing date
EDITAS MEDICINE INC28106W103COM41,324$992,000thousands by filing date
NANTHEALTH INC630104107CMN238,828$984,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock15,000$55,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000903423-17-000679this filing2017-11-15acceptance time not in the bulk data set